Bio-Techne Corporation
TECH
$60.24
$1.773.02%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 3.84% | -17.22% | -17.27% | 78.61% | -46.14% |
Total Depreciation and Amortization | -3.74% | 251.74% | -167.90% | -1.77% | -2.58% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -14.40% | -30.42% | 419.99% | -63.77% | 5,343.35% |
Change in Net Operating Assets | 225.24% | 4.87% | -869.05% | -92.91% | 193.99% |
Cash from Operations | 32.02% | -15.37% | -6.78% | -2.56% | 39.97% |
Capital Expenditure | 25.63% | 48.99% | -9.36% | -10.61% | -9.36% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | 100.00% | 98.03% |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 100.00% | -236.42% | -- | 100.00% | -121.33% |
Cash from Investing | 76.79% | -146.19% | 46.43% | 30.54% | 84.64% |
Total Debt Issued | -- | -- | -- | -100.00% | -59.38% |
Total Debt Repaid | 100.00% | 72.86% | -20.69% | 0.00% | 17.14% |
Issuance of Common Stock | -77.93% | 9.45% | 25.11% | 247.44% | -63.35% |
Repurchase of Common Stock | -1,437.74% | -1,139.80% | -139.29% | 99.79% | -301.01% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -0.38% | -0.48% | -0.38% | -0.16% | 0.75% |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -624.54% | 80.75% | -14.65% | 35.61% | -213.83% |
Foreign Exchange rate Adjustments | -206.90% | -3.18% | 325.19% | -168.54% | 139.38% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -127.95% | 201.02% | 21.39% | 152.79% | 41.92% |